Gene · 51455
Papers1,571
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,571
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| REV1 inhibition enhances trinucleotide repeat mutagenesis. | bioRxiv | 2025 | 41000971 | PubTator, text mining | PubMed |
| Investigation of radiation-induced DNA damage repair-related genes as diagnostic biomarkers for radiation. | J Radiat Res | 2025 | 40992406 | PubTator, text mining | PubMed |
| DNA polymerase kappa is the primary translesion synthesis polymerase for aldehyde ICLs. | Nucleic Acids Res | 2025 | 40985768 | PubTator, text mining | PubMed |
| Translesion polymerases and DNA-protein crosslink repair shapes the cellular response to formaldehyde-induced DNA damage in ssDNA. | Nucleic Acids Res | 2025 | 40966511 | PubTator, text mining | PubMed |
| Sensitization of cancer cells to DNA-damaging agents by expression of the REV1 C-terminal domain: Implications for chemotherapy. | Proc Natl Acad Sci U S A | 2025 | 40928869 | PubTator, text mining | PubMed |
| Bundle recommendation methods considering rating data differences for online retailers. | PLoS One | 2025 | 40901860 | PubTator, text mining | PubMed |
| WRN and WRNIP1 ATPases impose high fidelity on translesion synthesis by Y-family DNA polymerases. | Elife | 2025 | 40900148 | PubTator, text mining | PubMed |
| Identification of a PCNA-binding motif in human translesion DNA polymerase REV1 and structural basis of its interaction with PCNA. | J Biochem | 2025 | 40888629 | PubTator, text mining | PubMed |
| DNA double-strand break end resection factors and WRN facilitate mitotic DNA synthesis in human cells. | Nat Commun | 2025 | 40854910 | PubTator, text mining | PubMed |
| Unveiling Replication Timing-Dependent Mutational Biases: Mechanistic Insights from Gene Knockouts and Genotoxins Exposures. | Int J Mol Sci | 2025 | 40806440 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Transcription-coupled repair of crosslinking DNA damage. | DNA Repair (Amst) | 2025 | 40706399 | PubTator, text mining | PubMed |
| Methylglyoxal mutagenizes single-stranded DNA via Rev1-associated slippage and mispairing. | Nucleic Acids Res | 2025 | 40705923 | PubTator, text mining | PubMed |
| Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy. | Breast Cancer Res | 2025 | 40629431 | PubTator, text mining | PubMed |
| Location- and feature-based selection histories make independent, qualitatively distinct contributions to urgent visuomotor performance. | Elife | 2025 | 40471201 | PubTator, text mining | PubMed |
| Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases. | Int J Mol Sci | 2025 | 39859356 | PubTator, text mining | PubMed |
| Catalytic and noncatalytic functions of DNA polymerase κ in translesion DNA synthesis. | Nat Struct Mol Biol | 2025 | 39300172 | PubTator, text mining | PubMed |
| Molecular dependencies and genomic consequences of a global DNA damage tolerance defect. | Genome Biol | 2024 | 39741332 | PubTator, text mining | PubMed |
| The Impact of Oleuropein on Cisplatin-Induced Toxicity in Cochlear Cells in Relation to the Expression of Deoxyribonucleic Acid Damage-Associated Genes. | J Int Adv Otol | 2024 | 39158163 | PubTator, text mining | PubMed |
| Analysis of translesion polymerases in colorectal cancer cells following cetuximab treatment: A network perspective. | Cancer Med | 2024 | 39102671 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51455/papers?page=2